| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5576249 | The American Journal of Medicine | 2017 | 33 Pages |
Abstract
We describe the largest cohort to date of patients with well-defined monoclonal gammopathy-associated systemic capillary-leak syndrome. Preventive treatment with IVIg was the strongest factor associated with survival, suggesting the use of IVIg as the first line in prevention therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Marc MD, Marie MD, Wladimir MD, Jean-Christophe MD, PhD, Marc MD, PhD, Sophie MD, Antoine MD, Marc MD, PhD, François MD, Gilles MD, Laurent MD, PhD, Christian MD, PhD, David MD, PhD, Julie MD, Martin MD, PhD, Marie-Josée MD, Christine MD, Annick MD,